248 related articles for article (PubMed ID: 231736)
21. delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
Kluin-Neleman JC; Neleman FA; Meuwissen OJ; Maes RA
Vet Hum Toxicol; 1979 Oct; 21(5):338-40. PubMed ID: 516362
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
[TBL] [Abstract][Full Text] [Related]
23. [Drug treatment of nausea and vomiting caused by cancer chemotherapy].
Havsteen H; Kjaer M
Ugeskr Laeger; 1989 Feb; 151(7):430-4. PubMed ID: 2645736
[TBL] [Abstract][Full Text] [Related]
24. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
25. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
Orr LE; McKernan JF; Bloome B
Arch Intern Med; 1980 Nov; 140(11):1431-3. PubMed ID: 6254456
[TBL] [Abstract][Full Text] [Related]
26. Nabilone (Cesamet) for chemotherapy-induced nausea and vomiting.
Med Lett Drugs Ther; 2006 Dec; 48(1249/1250):103-4. PubMed ID: 17149361
[No Abstract] [Full Text] [Related]
27. Oral ondansetron for preventing nausea and vomiting.
Cooke CE; Mehra IV
Am J Hosp Pharm; 1994 Mar; 51(6):762-71. PubMed ID: 8010314
[TBL] [Abstract][Full Text] [Related]
28. Antiemetic therapy in patients treated with cisplatin chemotherapy.
Roila F; Basurto C; Bracarda S; Del Favero A; Tonato M
J Chemother; 1989 Jul; 1(4 Suppl):1281-5. PubMed ID: 16312866
[No Abstract] [Full Text] [Related]
29. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
Orr LE; McKernan JF
J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
[TBL] [Abstract][Full Text] [Related]
30. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.
Frytak S; Moertel CG; O'Fallon JR; Rubin J; Creagan ET; O'Connell MJ; Schutt AJ; Schwartau NW
Ann Intern Med; 1979 Dec; 91(6):825-30. PubMed ID: 517882
[TBL] [Abstract][Full Text] [Related]
31. Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
Wickham R
Cancer Control; 2012 Apr; 19(2 Suppl):3-9. PubMed ID: 22488022
[TBL] [Abstract][Full Text] [Related]
32. Antiemetic-induced akathisia in cancer patients receiving chemotherapy.
Fleishman SB; Lavin MR; Sattler M; Szarka H
Am J Psychiatry; 1994 May; 151(5):763-5. PubMed ID: 8166321
[TBL] [Abstract][Full Text] [Related]
33. Metoclopramide in the reduction of nausea and vomiting associated with combined chemotherapy.
Cox R; Newman CE; Leyland MJ
Cancer Chemother Pharmacol; 1982; 8(1):133-5. PubMed ID: 7046974
[TBL] [Abstract][Full Text] [Related]
34. Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting.
Swann IL; Thompson EN; Qureshi K
Br Med J; 1979 Nov; 2(6199):1188. PubMed ID: 519355
[No Abstract] [Full Text] [Related]
35. Antiemetic study design: a discussion of Dr Olver's paper.
Groshen S
Br J Cancer Suppl; 1992 Dec; 19():S35-7. PubMed ID: 1467199
[No Abstract] [Full Text] [Related]
36. Chemotherapy-induced nausea and vomiting.
Rittenberg CN; Cunningham RS
Clin J Oncol Nurs; 2005 Apr; 9(2):257-60. PubMed ID: 15853171
[No Abstract] [Full Text] [Related]
37. Incidence of nausea and vomiting induced by oxycodone administered with prochlorperazine in Japanese cancer patients.
Yamada T; Kanazawa Y; Aoki Y; Uchida E
J Nippon Med Sch; 2015; 82(2):100-5. PubMed ID: 25959201
[TBL] [Abstract][Full Text] [Related]
38. delta 9-tetrahydrocannabinol in clinical oncology.
Poster DS; Penta JS; Bruno S; Macdonald JS
JAMA; 1981 May 22-29; 245(20):2047-51. PubMed ID: 6262541
[TBL] [Abstract][Full Text] [Related]
39. Management of chemotherapy-induced nausea and vomiting.
Zubairi IH
Br J Hosp Med (Lond); 2006 Aug; 67(8):410-3. PubMed ID: 16918094
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.
Tsukuura H; Ando Y; Gyawali B; Matsumoto M; Sugishita M; Honda K; Urakawa H; Maeda O; Hasegawa Y
J Palliat Med; 2015 Nov; 18(11):977-80. PubMed ID: 26509390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
